Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 5/20 | 0.60 |
| ▸ | MME | P08473 | 5/20 | 0.52 |
| ▸ | ACE | P12821 | 4/20 | 0.52 |
| ▸ | CPA1 | P15085 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPY4R | P50391 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29822661 | 0.92 | MME (0.60) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL32665667 | 0.91 | MME (0.51) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL30483839 | 0.90 | ENPEP (0.62) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL27935801 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL27704335 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL4273365 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL4273366 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL6445682 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL27704333 | 0.90 | ACE (0.62) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL29351001 | 0.89 | ACE (0.61) | MMEACECPA1ACE2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2492 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230085176-A1 | PEPTIDE-BASED INHIBITORS OF GROWTH HORMONE ACTION AND METHODS OF USE THEREOF | OHIO UNIVERSITY (US) | 2023-03-16 | — | — | US | claimed |
| CN-106987570-B | Cas9 nuclease R780A and application thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122080238-A | RBoNT recombinant protein and precursor thereof, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| US-12559748-B2 | Compositions and methods for the treatment of hemoglobinopathies | NOVARTIS AG (CH) | 2026-02-24 | — | — | US | disclosed |
| US-20260034317-A1 | INHALER AND CAPSULE FOR DELIVERING THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES | MEDIMMUNE LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-12508303-B2 | Acetylation of Miro1 | UNIVERSITY OF SOUTH CAROLINA (US) | 2025-12-30 | — | — | US | disclosed |
| US-12486310-B2 | Metastasis inhibiting protein | BRIGHAM YOUNG UNIVERSITY (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2025242605-A1 | INHALER AND CAPSULE FOR DELIVERING THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES | MEDIMMUNE LIMITED (GB) | 2025-11-27 | — | — | WO | disclosed |
| CN-114008069-A | Compositions of exosomes and AAV | 科迪亚克生物科学公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-112698030-B | Kit for detecting novel coronavirus antibody based on enzyme-linked immunosorbent assay | 丹娜(天津)生物科技股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113999863-A | Method for improving water utilization efficiency of tomato crops | 浙江大学 | 2022-02-01 | — | — | CN | disclosed |
| CN-111676203-B | Leucine dehydrogenase mutant and application thereof | 江南大学 | 2022-02-01 | — | — | CN | disclosed |
| CN-112080503-B | Method for improving expression quantity of gamma-glutamine transpeptidase by optimizing promoter | 江南大学 | 2022-02-01 | — | — | CN | disclosed |
| CN-113980880-A | Genetically engineered bacterium, application thereof and method for producing psicose by taking glucose as raw material | 吉林中粮生化有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-107074948-B | Antibodies that bind AXL | 根马布股份公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993898-A | Human antibodies that bind RET and methods of use thereof | 瑞泽恩制药公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |